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Chronic oral and facial pain syndromes are an indication for intervention of physicians of numerous medical specialties, while
the complex nature of these complaints warrants interdisciplinary diagnostic and therapeutic approach. Oftentimes, lack of proper
differentiation of pain associated with pathological changes of the surrounding tissues, neurogenic pain, vascular pain, or radiating
pain from idiopathic facial pain leads to improper treatment. The objective of the paper is to provide detailed characterization of
pain developing in the natural history of trigeminal neuralgia and temporomandibular joint dysfunction, with particular focus on
similarities accounting for the difficulties in diagnosis and treatment as well as on differences between both types of pain. It might
seem that trigeminal neuralgia can be easily differentiated from temporomandibular joint dysfunction due to the acute, piercing,
and stabbing nature of neuralgic pain occurring at a single facial location to spread along the course of the nerve on one side,
sometimes a dozen or so times a day, without forewarning periods. Both forms differ significantly in the character and intensity of
pain. The exact analysis of the nature, intensity, and duration of pain may be crucial for the differential diagnostics of the disorders
of our interest.
1. Introduction
According to the definition provided by the International
Association for the Study of Pain, pain is a subjectively
unpleasant and negative sensory and emotional experience
occurring following activation of nociceptive stimuli that
damage the tissue. The character of pain depends on its
location, type of dysfunction of the particular region, and
stage of the disease. It is also an observation made during
mental interpretation of associated phenomena. Although
pain is associated with unpleasant sensations, it also plays a
positive forewarning and protective role. Pain is an extremely
complex neurophysiological process [1–12]. It appears as
the result of a damaging stimulus and the effect of tissue
hormones (serotonin, bradykinin, histamine, leukotriene,
and accumulation of hydrogen ions) on nociceptors, that is,
receptors specialized in the reception of pain and discomfort
sensations. Nociceptor excitability depends on physical stim-
uli, physiochemical milieu, and the quantities of endogenous
pain substances being secreted [2–6]. Factors such as micro-
circulation, dysregulation of the sympathetic nervous system,
and excessivemuscle tone affect the activity of pain receptors.
The process of the development of pain sensation is known as
nociception and consists of four stages: transduction, trans-
mission,modulation, and perception. Nociceptive stimuli are
transmitted by the neuronal route of the posterior spinal horn
and by the spinothalamic routes to cortical centers where
perception of pain sensations occurs [1, 2].
The objective of the paper is to provide detailed character-
ization of pain developing in the natural history of trigeminal
neuralgia and temporomandibular joint dysfunction, with
particular focus on similarities accounting for the difficulties
in diagnosis and treatment as well as on differences between
both types of pain.
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2. Craniofacial Pain
Chronic oral and facial pain syndromes are an indication for
intervention of physicians of numerous medical specialties,
while the complex nature of these complaints warrants
interdisciplinary diagnostic and therapeutic approach. The
incidence of oral and facial pains is estimated at 10% in
adults and 50% in elderly patients. Oftentimes, lack of
proper differentiation of pain associated with pathological
changes of the surrounding tissues, neurogenic pain, vascular
pain, or radiating pain from idiopathic facial pain leads to
improper treatment. Diseases that involve significant pain,
when inappropriately treated, lead to the reduction in the
quality of life and to the development of depressive disorders
[2–14].
Of the important data provided in medical interviews,
particular attention should be drawn to the time of the onset
of pain, pain location and characteristic, intensity, frequency
and factors that enhance or reduce the intensity of pain. Also
important is the radiation of pain to the surrounding organs
of anatomical structures [1–15].
Pain within the craniofacial area is one of the most
important reasons why patients present at the dentist’s office
[2–11]. Odontitis, periodontopathies, alveolar osteitis, nerve
injuries, atypical facial pains, neoplastic lesions, elongated
styloid process syndrome (Eagle’s) syndrome, and reflex sym-
pathetic dystrophy of the face should be taken into account.
Common causes of pain include trigeminal neuralgia (most
commonly of the third branch of the trigeminal nerve,
i.e., the mandibular nerve) and temporomandibular joint
dysfunction. In the differential diagnostics of facial pains,
disease duration of several months or several years required
unified diagnostic criteria with consideration of nontypical
cases. In the therapy, we use various methods of treatment
such asmedication, surgery, dental prosthetic, physiotherapy,
and psychological support [2–36].
3. Trigeminal Neuralgia
Neuralgia is a symptom of nerve dysfunction present within
the brain stem or within the nerve segment running to the
trigeminal ganglion located within the base of the middle
cranial fossa. The disorder is most common in patients
over 60 years of age and more common in women. Main
etiological factors responsible for neuralgia include vascu-
loneural conflict consisting in compression of the nerve by
blood vessels at the site of neural connection to the brain
stem, within the region of the superior cerebellar artery, the
basilar artery, the vertebral artery, and the petrosal vein.
In addition, neuralgia may be a result of head injuries
or inflammation of nerve within the myelin sheath. The
disorder may also be associated with other diseases such as
multiple sclerosis (formation of demyelinating plaque in the
brain) or tumors that compress the nerve and disturb its
function [4, 8–17, 23]. According to the most recent theory
of magnetic bioresonance, trigeminal nerve starts oscillating
at amplitudes that exceed its natural frequency. The human
organs differ in their natural frequencies (8–12Hz for the
head). The nerve is immersed in the cerebrospinal fluid that
transmits the vibrations of the surrounding structures [5, 9].
The increase in the amplitude of vibrations damages the
permeability of ion channels, leading to nerve injury. The
disorder is characterized by recurrent, paroxysmal attacks of
sudden, intense, and piercing pain within the region supplied
by the trigeminal nerve, comparable to an electric shock [5–
7, 9–19, 30].
It might seem that trigeminal neuralgia can be easily
differentiated from temporomandibular joint dysfunction
due to the acute, piercing, and stabbing nature of neuralgic
pain. It should be mentioned that neuralgia may be of either
spontaneous (primary) or symptomatic (secondary) form.
Both forms differ significantly in the character and intensity
of pain. Unexplained etiology of spontaneous neuralgias
of the second and third branch of the trigeminal nerve
is a cause of significant therapeutic problems [1–8, 10–15].
Both branches may also be affected at the same time. The
incidence is 1 in 15,000 cases. The acute, paroxysmal, and
piercing pain occurs at a single facial location to spread
along the course of the nerve on one side, sometimes a
dozen or so times a day, without forewarning periods. Pain
episodes may last several seconds to several minutes. As the
disease progresses, the number of episodes increases and the
remission periods become shorter. The pain is intensified
during facial muscle and mandibular movements. Primary
neuralgia is often accompanied by facial muscle contractures
(tic douloureux), increased salivation, lachrymation, running
nose, and skin redness. Stimuli that most commonly cause
the pain are trivial and everyday causes such as wind gusts,
sudden changes in air temperature, bright light, sharp sounds,
or delicate touch (e.g., shaving in males). A typical feature of
these disorders is the unilateral occurrence of pain and lack
of complaints during the night’s sleep [3, 5, 7, 9–13, 15].
In contrast to the spontaneous neuralgia, its symptomatic
(secondary) form is associated with pain that increases grad-
ually, has different nature, and persists with no interruptions.
The pain becomes intensified in heat. It may be a result of
numerous local or generalized causes (odontitis, cysts, sharp
socket edges, tumors within the mouth, and the maxillo-
ethmoidal massif, disorders of the maxillary sinuses or the
middle ear). Neuralgia of this type may be a symptom of
numerous diseases within the region of the posterior cranial
fossa, such as basal tumors or cerebellopontine angle tumors.
This type of neuralgia may also be observed in alcohol,
mercury, or nicotine intoxication [8–13, 15, 18, 30].
Symptomatic neuralgia should be differentiated from
causalgia which may be due to the traumatic injury of nerve,
particularly maxillary nerve, or mandibular nerve within the
facial region. Causalgia may develop as a result of contusion,
fracture, or surgical intervention in this region. As shown by
the characteristic of pain, primary neuralgia is substantially
different from the secondary form. Therefore, the pain asso-
ciated with the temporomandibular joint dysfunction may
have a characteristic that is similar to the secondary neuralgia
andmaypose significant difficulties in differential diagnostics
[4, 5, 8–10, 13, 14].
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Table 1: Differential characteristics of pain in the course of trigeminal neuralgia and temporomandibular joint dysfunction.
Common features of pain in trigeminal
neuralgia and temporomandibular joint
dysfunctions
Differential characteristics of pain in the course of trigeminal neuralgia and
temporomandibular joint dysfunction
Trigeminal neuralgia Temporomandibular joint dysfunctions
Increase in pain as a result of activity of
facial or masticatory muscles Unilateral location of pain (97%) Bilateral pain
Possibility of pain being located on one
side of the face
Characteristics of pain: acute and
stabbing
Characteristics of pain: continuous and
dull
Possibility of otolaryngological symptoms Remission of the neuralgic pain duringnights Pain may still be present during the nights
Significant reduction in patients’ quality
of life and the development of depressive
disorders
The duration of pain: very short, lasting
several seconds to several minutes with
long periods of remission during the day
The duration of pain: long-lasting
(several hours) with short intermissions
Pain being radiated into the neighboring
regions
Pain accompanied by facial muscle
convulsions (tics), skin redness,
lachrymation
Lack of such symptoms
4. Temporomandibular Joint Dysfunction
According to WHO report, temporomandibular joint dys-
function is the third stomatological disorder to be considered
a populational disease, after dental caries and periodontal
diseases. Temporomandibular joint dysfunction consists in
a spectrum of changes disturbing the morphological and
physiological balance within themusculoskeletal system.The
nature of these changes is determined by psychoemotional,
environmental, and genetic factors. The changes include
abnormalities in the relationship between opposing teeth,
and the function of the muscles of the frontal and medial
part of the skull and neck, working in a symmetrical manner
in physiological conditions of the temporomandibular joints.
Increasing stress levels lead to intensification of adverse
motion habits within the stomatognathic system and the
rapid increase in the number of patients observed in recent
years is associated with the drop in the age of patients with
dysfunctions manifested with pain symptoms [14, 15, 17, 18].
Functional disorders of the masticatory organ are
pathologies of diverse etiology [2]. The incidence of the
painful form of the disorders is estimated at about 30% of all
cases. Most commonly, pain is located within the temporo-
mandibular joint region or, less commonly, the masticatory
muscles (myalgia). It may range from slight tenderness to a
very strong discomfort. The pain is either acute and stab-
bing or chronic, diffuse and radiating into the neighboring
structures, that is, eyes, ears, temples, and occiput. It is not
associated with inflammation; the intensity of muscle pain
is closely related to excessive functional activity of particular
muscle groups during occlusal parafunctions. Overburdened
muscles are characterized by hypoxia and ischemia and thus
with the release of allogeneic substances that determine the
resultant pain, such as bradykinin or prostaglandins. Muscle
tenderness is a source of deep pain andmay lead to protective
contractures [2–5, 18, 19].
The articular pain is a result of damage to articular sur-
faces, degeneration, injuries of articular capsule, or damage
of retrodiscal tissue. Arthralgia may develop only as a result
of impulsation originating from nociceptors located within
the soft tissue. Lack of coordination of mandibular head and
disc is manifested by acoustic symptoms within the tem-
poromandibular joints, such as popping and cracking sounds
upon mandibular movements. At advanced stages of disc
translocation and blockade, acoustic symptoms disappear to
be replaced by chronic pain and significant restriction of jaw
opening range, complicated by tilting the mandible towards
the affected side upon abduction. Temporomandibular pains
may also be the result of prolonged overload of articu-
lar structures of high intensity, exceeding the adaptational
capabilities of the collagen fibers within the posterior disc
ligament, which are commonly subject to fragmentation.
The nature of the pain observed in temporomandibular
joint dysfunction is similar to that in the symptomatic form
of neuralgia and significantly different from that in the
spontaneous neuralgia [2, 15–28].
5. Common Features of Both Types of Pain
Pains sensations experienced in trigeminal neuralgia and
temporomandibular joint dysfunction have both common
features and significant differences (Table 1). Common fea-
tures include pain being radiated into the neighboring
regions, and even to distant structures, possibility of pain
being located on one side of the face, increase in pain as a
result of increased activity of facial or masticatory muscles
and the possibility of otolaryngological symptoms (earache
and hearing impairment) [16]. In addition, the diffuse pain
that lasts for many months in both cases may lead to
significant reduction in patients’ quality of life and to the
development of depressive disorders. Compared to primary
neuralgia, pain experienced in secondary neuralgia is much
more similar to that observed in functional disorders [2, 15,
17–20].
6. Differences in the Characteristics of Pain
Features differentiating both nosocomial entities include
unilateral location of pain in neuralgia (97%) and bilateral
pain in myalgia. Also the nature of pain is different, being
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Figure 1: Diagnostic and therapeutic management of patients suffering from trigeminal neuralgia.
acute and stabbing in neuralgia and continuous, dull in
temporomandibular joint dysfunction. Night’s rest is a period
of remission of the neuralgic pain, while temporomandibular
joint pain may still be present in this period in case of
functional disorders [13–16]. The duration of pain is also
different: the neuralgic pain is very short (lasting several
seconds to several minutes), with long periods of remission
during the day, while the dysfunctional pain is long-lasting
(several hours) with short intermissions. Pain episodes in
spontaneous neuralgia are induced by triggering stimuli
which are usually the same in particular patient. Patients tend
to avoid these stimuli and are afraid of them. If neuralgia
episodes are induced by chewing, patients fast deliberately,
which leads to secondary and multiplanar somatic disorders.
Neuralgic pains are often accompanied by facial muscle
convulsions (tics), skin redness, lachrymation, which are
not observed in temporomandibular joint dysfunction. In
neuralgia, pain is intensified by heat, while being alleviated
in myalgia [2–5, 9–35].
Thanks to the development of neurophysiological exam-
inations, magnetic resonance imaging, cerebral angiography,
and clinical symptoms, trigeminal neuralgia may be correctly
diagnosed while excluding other causes for paroxysmal facial
pains. The exact analysis of the nature of pain may be crucial
for the differential diagnostics of the disorders of our interest
[3, 10, 22, 36–48].
Despite similarities of pain symptoms in both types of
pathologies, therapeutic management is different in both
cases. In trigeminal neuralgia, treatment involves conserva-
tive andmore or less invasivemethods. Usually, the treatment
is commenced carbamazepine (100 to 1000mg/day) phar-
macotherapy, in some cases combined with anticonvulsants
(phenytoin, clonazepam). One should also keep in mind the
ability to achieve long-term remission of neuralgic pains by
means of neural blockades of the terminal trigeminal nerve
branches using lidocaine or bupivacaine solutions (Figure 1).
The next step consists in surgical treatment; however, the use
of surgical methods, even in the form of minor procedures
such as neurotomy or exeresis, requires that the patient
should be qualified for the surgery by both internal medicine
specialist and anesthesiologist which constitutes a major
problem, considering the commonly elderly age of patients
combined with significant burden of concomitant diseases
[10, 36–39, 42].
The latest method is stereotactic surgery/gamma knife,
making use of electromagnetic gamma radiation from cobalt
60Co isotope sources, corpuscular radiation of protons of
heavy carbon ions, or electromagnetic X radiation gener-
ated by linear accelerators. The method was developed by
professor Lars Leksel and has been known since 1967. The
method consists in precise delivery of radiation from 192
collimator sources into intracranial pathological lesions using
stereotactic techniques. The first stage of the procedure is
the placement of stereotactic frame on patient’s head using
special screws in local anesthesia. The patient is placed
within a gamma knife apparatus, where the irradiation spot
location and dose magnitude is determined on the basis
of magnetic resonance scan results and the location of the
lesion. The usual dose is 90Gy and is absolutely safe for
tissues permeated by radiation. Irradiation lasts about 30
minutes. Factors taken into consideration when qualifying
patients for the treatment include the type, size, and location
of lesions. Radiosurgery techniques have witnessed an enor-
mous technological progress. At the same time, a model of
multidisciplinary teams of oncologists, radiotherapists, neu-
rosurgeons, and othermedical specialties has been developed
for the radiosurgery purposes. The efficacy of stereotactic
radiosurgery is estimated at 80–90%. Due to the minimum
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invasiveness of the procedure, it is the method of choice in
elderly patients or patients with high concomitant disease
load [42, 49].
Due to the poor availability of this treatment in Poland,
microvascular decompression (MVD) technique is still in
use, consisting of craniotomy followed by elimination of the
vasculoneural conflict by means of separating the problem-
atic artery or vain from the nerve using autogenic (muscle
fragment) or alloplastic (teflon, goretex) material [5, 8, 10, 14,
32].
The natural history of temporomandibular joint dysfunc-
tionmost commonly involves changes in the biomechanics of
temporomandibular joints connectedwith the dysfunction of
masticatory muscles. The treatment of functional disorders
usually involves occlusal splints, characterized by multiple
effects. These include elimination or reduction of pain by
reducing the load on temporomandibular joints and retrodis-
cal structures as well as reduction of excessive activity and
restoration of symmetry in the tone of masticatory muscles.
This is known as reversible occlusal treatment. Prosthetic
methods for the treatment of dysfunction include procedures
to correct the occlusion system (selective contouring, recon-
struction of correct occlusal conditions with fixed or mobile
prostheses) [1–3, 5, 8, 18, 25–29, 41, 44, 47, 48].
Physiotherapy plays an important role in the treatment
of patients with temporomandibular joint dysfunctions when
used as an element of supportive therapy applied simultane-
ously to the primary treatment.The goal of physiotherapeutic
procedures is to eliminate or reduce pain, reduce the excessive
tone of overloaded muscles of the head, neck, and shoulder
girdle, activate muscles of reduced muscle tone, and mobilize
joints of limited mobility. The techniques used in physical
therapy affect motor coordination of the musculoskeletal
system and have beneficial effect on the increased vascular
flow in the treated area. Physiotherapeutic methods used
in stomatology include kinesitherapy, laser therapy, manual
therapy, massage, light therapy, electrotherapy, and magne-
toledtherapy [2, 15, 19, 21, 23, 33, 38].
A new pharmacological approach consists of the use
of botulinum toxin type A in the treatment of excessive
muscle tone which constitutes a serious problem in the
natural history of the temporomandibular joint dysfunction
[26, 28, 29]. The mechanism of action of the drug involves
suppression of the release of acetylcholine (parasympathetic
neurotransmitter) into the synaptic cleft and blockade of
the transmission of impulses leading to muscle contracture.
Intramuscular injections of the toxin are administered in the
region of the largest cross section of the masseter muscle.
The duration of the relaxant effect of the drug depends on
the dose strength; most usually, it is 6 months [26]. There are
several other medicines like Propolis or topical application of
Ketoprofen in the area of temporomandibular joints [22, 23,
31].
7. Summary
Chronic oral and facial pain syndromes are an indication for
intervention of physicians of numerous medical specialties,
while the complex nature of these complaints warrants
interdisciplinary diagnostic and therapeutic approach. The
precise analysis of characteristic features of pain, its intensity,
and duration may be crucial for the differential diagnostics
of trigeminal neuralgia and functional disorders of the
masticatory apparatus [2–4, 8, 13–15, 19, 50–53].
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